Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04229355
What this trial is testing

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06494943
What this trial is testing

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Fudan University 27
Testing effectiveness (Phase 2)Looking for participantsNCT06831175
What this trial is testing

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Who this might be right for
Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
West China Hospital 28
Testing effectiveness (Phase 2)UnknownNCT04892498
What this trial is testing

Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

Who this might be right for
Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University 66
Not applicableUnknownNCT05032014
What this trial is testing

Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jiangxi Provincial Cancer Hospital 46
Early research (Phase 1)UnknownNCT05202561
What this trial is testing

RNA Tumor Vaccine in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
The First Affiliated Hospital of Bengbu Medical University 10
Testing effectiveness (Phase 2)Study completedNCT03427411
What this trial is testing

M7824 in Subjects With HPV Associated Malignancies

Who this might be right for
Human Papilloma VirusCervical CancerOropharyngeal Cancer+2 more
National Cancer Institute (NCI) 57
Very early researchLooking for participantsNCT07689643
What this trial is testing

Safety and Preliminary Efficacy of [177Lu]Lu-RTX-2358 Combined With Immune Checkpoint Inhibitors in Patients With FAP-positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)UnknownNCT05564897
What this trial is testing

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Zhejiang Cancer Hospital 25
Early research (Phase 1)UnknownNCT05644509
What this trial is testing

Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor

Who this might be right for
Advanced Solid Tumor
The Affiliated Hospital of Xuzhou Medical University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05993858
What this trial is testing

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Not applicableEnded earlyNCT04734704
What this trial is testing

Defining the Role of the Skin Microbiome in Immune-related Adverse Events

Who this might be right for
VitiligoSkin Melanoma
University Hospital, Bordeaux 57
Large-scale testing (Phase 3)Active Not RecruitingNCT05840016
What this trial is testing

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non Small Cell Lung Cancer
Akeso 532
Testing effectiveness (Phase 2)UnknownNCT05871684
What this trial is testing

A Combination Study of CAR-T Therapy in r/r B-NHL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06809530
What this trial is testing

Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal MetastasisPemetrexedPD-1 Inhibitor+2 more
Guangzhou Medical University 34
Not applicableStudy completedNCT07256184
What this trial is testing

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Who this might be right for
Metastatic Malignant Melanoma
Ankara Etlik City Hospital 232
Testing effectiveness (Phase 2)UnknownNCT05675033
What this trial is testing

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaStage IV Non-small Cell Lung CancerPD-1 Inhibitor+1 more
Fujian Cancer Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06751849
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Large-scale testing (Phase 3)Looking for participantsNCT07524452
What this trial is testing

Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ming-Yuan Chen 430
Testing effectiveness (Phase 2)Looking for participantsNCT06561308
What this trial is testing

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Who this might be right for
Endometrioid Endometrial Cancer
Women's Hospital School Of Medicine Zhejiang University 39
Next Page